Glucocorticoid treatment in horses with asthma: A narrative review.

The research article is a comprehensive review of the use of glucocorticoids (GC) in the treatment of asthma in horses. It presents an analysis of various GC-based drugs, their effects on lung function, airway inflammation, and bronchial remodeling, as well as potential adverse effects.

Objective of the Review

The team behind this review aimed to gather, analyse, and compare all available information on the use of glucocorticoids for treating asthma in horses. Their focus was on how these drugs impact lung function, airway inflammation, and bronchial remodeling. The authors also aimed to illuminate any understudied or underreported areas that could benefit from future research.

• The investigators sought to pinpoint the efficacy of different glucocorticoid drugs.
• The determination of minimal effective doses was another aspect they wanted to explore, to understand how much of each GC drug is needed to produce a beneficial effect on horses’ respiratory health.
• The researchers also wanted to unpick the complex processes that lead to varying responses in airway inflammation between different horses.

Why Glucocorticoids?

Glucocorticoids have long been the drug treatment of choice for asthmatic horses. The drug’s successful track record in substantially relieving airway obstruction explains their continued appeal, despite potential harmful side effects.

• Glucocorticoids have been found to be highly effective in reducing obstruction in the airways of asthmatic horses, providing them immediate relief.
• Despite their potential side effects, the drug’s efficacy at treating the major symptoms of asthma maintains them as a standard treatment option.

Need for More Research

The researchers firmly emphasized the need for more in-depth studies and information regarding the use of glucocorticoids in treating asthmatic horses.

• They highlight the need to compare the efficacy of different glucocorticoid drugs and establish the minimum effective doses.
• The study also underlines the necessity for a better comprehension of the mechanisms behind the varied effects of glucocorticoids on airway inflammation in different horses. This could potentially lead to more personalized treatment strategies, maximizing the drug’s effectiveness while minimizing its potential adverse effects.
• Adverse effects, though acknowledged, were only briefly examined, calling for more concentrated focus on this aspect in future studies.

Summary

This narrative review offers a comprehensive analysis of the use of glucocorticoids for treating asthmatic horses, bringing together a plethora of information from numerous sources. It also highlights the critical areas where future research efforts should be concentrated to ensure more efficient and safer treatment strategies for asthmatic horses.